HHV-8-Associated Lymphoproliferative Disorders and Pathogenesis in an HIV-Positive Patient

Human herpesvirus 8 (HHV-8), also known as Kaposi’s sarcoma-associated herpesvirus, is a DNA oncovirus known for its role in the development of Kaposi’s sarcoma (KS) and several lymphoproliferative disorders (LPDs). HHV-8 promotes lymphoproliferation via the activation of the interleukin-6 receptor...

Full description

Saved in:
Bibliographic Details
Main Authors: Carlo Guerrero, Tania Jain, Katalin Kelemen
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2019/4536157
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567034440843264
author Carlo Guerrero
Tania Jain
Katalin Kelemen
author_facet Carlo Guerrero
Tania Jain
Katalin Kelemen
author_sort Carlo Guerrero
collection DOAJ
description Human herpesvirus 8 (HHV-8), also known as Kaposi’s sarcoma-associated herpesvirus, is a DNA oncovirus known for its role in the development of Kaposi’s sarcoma (KS) and several lymphoproliferative disorders (LPDs). HHV-8 promotes lymphoproliferation via the activation of the interleukin-6 receptor signaling pathway, as well as a host of other regulatory mechanisms. The spectrum of HHV-8-associated LPDs is increasing. The World Health Organization has recently updated the classification of HHV-8-associated LPDs by introducing HHV-8-positive germinotropic LPD (GLPD) in addition to the previously recognized entities of HHV-8-positive diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS), primary effusion lymphoma (PEL), and HHV-8-positive multicentric Castleman’s disease (MCD). We present here a case of an HIV-positive woman with a history of KS, who later developed three HHV-8-associated LPDs, including HHV-8-positive MCD, PEL, and GLPD. To the best of our knowledge, this is the first reported case of a patient with this combination of individually rare HHV-8-associated LPDs. This case illustrates the spectrum and the sequential development of the different clinical manifestations of HHV-8-associated diseases. Detection of HHV-8 can have clinical significance in the diagnosis and management of certain HHV-8-associated conditions. Recently discovered variants of HHV-8-associated LPDs indicate that this group represents a diverse spectrum of disorders, whose classification may require further refinement beyond the currently recognized entities.
format Article
id doaj-art-54315b98127f4359ade3aed38603549b
institution Kabale University
issn 2090-6560
2090-6579
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-54315b98127f4359ade3aed38603549b2025-02-03T01:02:30ZengWileyCase Reports in Hematology2090-65602090-65792019-01-01201910.1155/2019/45361574536157HHV-8-Associated Lymphoproliferative Disorders and Pathogenesis in an HIV-Positive PatientCarlo Guerrero0Tania Jain1Katalin Kelemen2Department of Medicine, Houston Methodist Hospital, Houston, TX, USAAdult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, USADepartment of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ, USAHuman herpesvirus 8 (HHV-8), also known as Kaposi’s sarcoma-associated herpesvirus, is a DNA oncovirus known for its role in the development of Kaposi’s sarcoma (KS) and several lymphoproliferative disorders (LPDs). HHV-8 promotes lymphoproliferation via the activation of the interleukin-6 receptor signaling pathway, as well as a host of other regulatory mechanisms. The spectrum of HHV-8-associated LPDs is increasing. The World Health Organization has recently updated the classification of HHV-8-associated LPDs by introducing HHV-8-positive germinotropic LPD (GLPD) in addition to the previously recognized entities of HHV-8-positive diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS), primary effusion lymphoma (PEL), and HHV-8-positive multicentric Castleman’s disease (MCD). We present here a case of an HIV-positive woman with a history of KS, who later developed three HHV-8-associated LPDs, including HHV-8-positive MCD, PEL, and GLPD. To the best of our knowledge, this is the first reported case of a patient with this combination of individually rare HHV-8-associated LPDs. This case illustrates the spectrum and the sequential development of the different clinical manifestations of HHV-8-associated diseases. Detection of HHV-8 can have clinical significance in the diagnosis and management of certain HHV-8-associated conditions. Recently discovered variants of HHV-8-associated LPDs indicate that this group represents a diverse spectrum of disorders, whose classification may require further refinement beyond the currently recognized entities.http://dx.doi.org/10.1155/2019/4536157
spellingShingle Carlo Guerrero
Tania Jain
Katalin Kelemen
HHV-8-Associated Lymphoproliferative Disorders and Pathogenesis in an HIV-Positive Patient
Case Reports in Hematology
title HHV-8-Associated Lymphoproliferative Disorders and Pathogenesis in an HIV-Positive Patient
title_full HHV-8-Associated Lymphoproliferative Disorders and Pathogenesis in an HIV-Positive Patient
title_fullStr HHV-8-Associated Lymphoproliferative Disorders and Pathogenesis in an HIV-Positive Patient
title_full_unstemmed HHV-8-Associated Lymphoproliferative Disorders and Pathogenesis in an HIV-Positive Patient
title_short HHV-8-Associated Lymphoproliferative Disorders and Pathogenesis in an HIV-Positive Patient
title_sort hhv 8 associated lymphoproliferative disorders and pathogenesis in an hiv positive patient
url http://dx.doi.org/10.1155/2019/4536157
work_keys_str_mv AT carloguerrero hhv8associatedlymphoproliferativedisordersandpathogenesisinanhivpositivepatient
AT taniajain hhv8associatedlymphoproliferativedisordersandpathogenesisinanhivpositivepatient
AT katalinkelemen hhv8associatedlymphoproliferativedisordersandpathogenesisinanhivpositivepatient